Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biochemistry|March 27, 2002
Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimersCatelijne Stortelers, Monique L M van De Poll, Anne E G Lenferink, et al.
The Journal of Biological Chemistry|October 13, 2006
Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligandsSebastian P van der Woning, Walter van Rotterdam, Sander B Nabuurs, et al.
ACS Chemical Neuroscience|October 23, 2018
Anti-TTR Nanobodies Allow the Identification of TTR Neuritogenic Epitope Associated with TTR-Megalin Neurotrophic ActivitiesJoão R Gomes, Zsuzsa Sárkány, Anabela Teixeira, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus InfectionLaurent Detalle, Thomas Stohr, Concepción Palomo, et al.
Frontiers in Immunology|December 8, 2018
CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma CellsKerstin Schütze, Katharina Petry, Julia Hambach, et al.
Plos One|October 28, 2014
Protective effect of different anti-rabies virus VHH constructs against rabies disease in miceSanne Terryn, Aurélie Francart, Sophie Lamoral, et al.
Frontiers in Pharmacology|October 27, 2022
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVsCarolina Pinto-Espinoza, Charlotte Guillou, Björn Rissiek, et al.
Molecular and Cellular Biology|June 20, 2006
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during developmentLaurens A van Meeteren, Paula Ruurs, Catelijne Stortelers, et al.
Frontiers in Immunology|April 27, 2017
Large Diversity of Functional Nanobodies from a Camelid Immune Library Revealed by an Alternative Analysis of Next-Generation Sequencing DataPieter Deschaght, Ana Paula Vintém, Marc Logghe, et al.
The Journal of Biological Chemistry|August 28, 2013
Llama-derived single variable domains (nanobodies) directed against chemokine receptor CXCR7 reduce head and neck cancer cell growth in vivoDavid Maussang, Azra Mujić-Delić, Francis J Descamps, et al.
Pageof 3